No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
HIMS240726P21500
- 1.50
- -0.70-31.82%
15min DelayTrading Jul 22 10:21 ET
1.73High1.50Low
1.73Open2.20Pre Close2 Volume331 Open Interest21.50Strike Price323.00Turnover80.68%IV2.27%PremiumJul 26, 2024Expiry Date1.04Intrinsic Value100Multiplier4DDays to Expiry0.47Extrinsic Value100Contract SizeAmericanOptions Type-0.6872Delta0.1939Gamma15.16Leverage Ratio-0.0734Theta-0.0017Rho-10.42Eff Leverage0.0080Vega
Intraday
- 5D
- Daily
News
Express News | Hims & Hers Health Inc: Schultz Joins Board to "Help Company Increase Access to Health and Wellness Solutions"
Express News | Pharmaceutical Industry Chief Kåre Schultz Joins Hims & Hers Board
Express News | Hims & Hers Health Shares Are Trading Lower Following a Report Suggesting That the Company Is Voluntarily Cooperating With a FTC Inquiry
Hims & Hers Says 'Voluntarily Cooperating' With FTC Inquiry
Hims & Hers Says 'Voluntarily Cooperating' With FTC
Truist Securities Adjusts Price Target on Hims & Hers Health to $23 From $13, Maintains Hold Rating
Hims & Hers Health (HIMS) has an average outperform rating and price target range of $13 to $26, according to analysts polled by Capital IQ.Price: 22.00, Change: +0.01, Percent Change: +0.05
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Announces Target Price $23
Truist Financial analyst Jailendra Singh maintains $Hims & Hers Health(HIMS.US)$ with a hold rating, and sets the target price at $23.According to TipRanks data, the analyst has a success rate of 37.0
Comments
Jim Cramer shared his perspective on Hims & Hers Health, highlighting its recent performance and potential. He suggested that while buying after its pullback to $20 from recent highs around $25 might be justified, caution is advised. Cramer noted the company's strength in telehealth services, particularly in areas like sexual health and mental health, which have seen robust growth.
He emphasized that while Hims & Hers has benefited from offering compounded ...
He emphasized that while Hims & Hers has benefited from offering compounded ...
From YouTube
7
Today grabbing
$Dave Inc(DAVE.US$
PT $41+ SL $27
$Desktop Metal(DM.US$
LT PT: $17+
$Hims & Hers Health(HIMS.US$
LT PT: $39.27+
$Intel(INTC.US$
PT: $50 SL: $25
Medium duration, 14-30 days min.
$Dave Inc(DAVE.US$
PT $41+ SL $27
$Desktop Metal(DM.US$
LT PT: $17+
$Hims & Hers Health(HIMS.US$
LT PT: $39.27+
$Intel(INTC.US$
PT: $50 SL: $25
Medium duration, 14-30 days min.
3
1. $Tesla(TSLA.US$ -- Often assessed by traditional auto industry metrics, Tesla's Full Self-Driving technology is overlooked, which shifts the focus from selling cars to providing autonomous ride services.
2. $SoFi Technologies(SOFI.US$ -- Regarded as just another fintech company, SoFi distinguishes itself with a unified financial platform that spans loan refinancing, investment services, and per...
2. $SoFi Technologies(SOFI.US$ -- Regarded as just another fintech company, SoFi distinguishes itself with a unified financial platform that spans loan refinancing, investment services, and per...
11
3
1. $Palantir(PLTR.US$
It is referred as the “Messi of AI”.
This is well deserved as customers are flocking to its AIP.
It allows companies to integrate their data and create customized LLMs for their operations.
This translated to a 40% year-over-year increase in U.S. commercial sales to $150 million and 27% worldwide commercial sales growth to $299 million.
Annual revenue is set to grow at 30% CAGR in the next 5 years.
2. $NVIDIA(NVDA.US$
...
It is referred as the “Messi of AI”.
This is well deserved as customers are flocking to its AIP.
It allows companies to integrate their data and create customized LLMs for their operations.
This translated to a 40% year-over-year increase in U.S. commercial sales to $150 million and 27% worldwide commercial sales growth to $299 million.
Annual revenue is set to grow at 30% CAGR in the next 5 years.
2. $NVIDIA(NVDA.US$
...
+1
22
1
$Hims & Hers Health(HIMS.US$ Jesus we get it guys you sold some fake fat pills relax people want skinny every thing diet is bad for you 😂
Read more